Balyasny Asset Management LLC Eli Lilly & CO Put Options Transaction History

Balyasny Asset Management LLC

10 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2024 May 13, 2024	SELL	$592.2 - $792.28 $34.8 Million - $46.5 Million	-58,700 Reduced 85.32%	10,100 $7.86 Million
Q4 2023 Feb 14, 2024	SELL	$525.19 - $619.13 $160 Million - $188 Million	-304,400 Reduced 81.56%	68,800 $40.1 Million
Q3 2023 Nov 14, 2023	BUY	$434.7 - $599.3 $66.2 Million - $91.2 Million	152,200 Added 68.87%	373,200 $200 Million
Q2 2023 Aug 14, 2023	BUY	$350.74 - $468.98 $77.1 Million - $103 Million	219,800 Added 18316.67%	221,000 $104 Million
Q1 2023 May 15, 2023	BUY	$310.63 - $364.82 $372,756 - $437,784	1,200 New	1,200 $412,000

Q2 2022 Aug 15, 2022	SELL	$278.73 - $327.27 $35.9 Million - $42.2 Million	-128,800 Reduced 96.26%	5,000 $1.62 Million
Q2 2021 Aug 16, 2021	BUY	$180.55 - $233.54 $6.1 Million - $7.89 Million	33,800 Added 33.8%	133,800 $30.7 Million
Q3 2019 Nov 14, 2019	BUY	$106.79 - $116.16 $4.91 Million - $5.34 Million	46,000 Added 85.19%	100,000 $11.2 Million
Q1 2019 May 15, 2019	SELL	$111.31 - $131.02 $57.2 Million - $67.3 Million	-514,000 Reduced 90.49%	54,000 $7.01 Million
Q3 2018 Nov 14, 2018	BUY	$85.86 - $107.31 $48.8 Million - $61 Million	568,000 New	568,000 $60.4 Million

3,719

738M

7.09M

7.24M

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $860B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Balyasny Asset Management LLC with notifications on news.